Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

Nicholas O. Opoku, Didier K. Bakajika, Eric M. Kanza, Hayford Howard, Germain L. Mambandu, Amos Nyathirombo, Maurice M. Nigo, Kambale Kasonia, Safari L. Masembe, Mupenzi Mumbere, Kambale Kataliko, Jemmah P. Larbelee, Mawolo Kpawor, Kpehe M. Bolay, Fatorma Bolay, Sampson Asare, Simon K. Attah, George Olipoh, Michel Vaillant, Christine M. HalleuxAnnette C. Kuesel*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

79 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences